Financials

ODI Pharma AB - Financial Results

Financial Results

ODI Pharma AB

Half-year Report Q2 ODI Pharma AB as of 31/12/2023

Quarterly Report Q1 ODI Pharma AB as of 30/09/2023

Annual Report 2022/2023 ODI Pharma [ENG, unofficial translation]

Årsredovisning/Annual Report 2022/2023 [SWE]

Year-end Report Q4 ODI Pharma AB as of 30/06/2023

Quarterly Report Q3 ODI Pharma AB as of 31/03/2023

Half-year Report Q2 ODI Pharma AB as of 31/12/2022

Quarterly Report Q1 ODI Pharma AB as of 30/09/2022

Årsredovisning/Annual Report 2021/2022 [SWE]

Annual Report 2021/2022 ODI Pharma [ENG, unofficial translation]

Year-end Report Q4 ODI Pharma AB as of 30/06/2022

Quarterly Report Q3 ODI Pharma AB as of 31/03/2022

Half-year Report Q2 ODI Pharma AB as of 31/12/2021

Quarterly Report Q1 ODI Pharma AB as of 30/09/2021

Årsredovisning/Annual Report 2020/2021 [SWE]

Annual Report 2020/2021 ODI Pharma [ENG, unofficial translation]

Year-end Report Q4 ODI Pharma AB as of 30/06/2021

Third Quarter Report Q3 ODI Pharma AB as of 31/03/2021

Half-year Report Q2 ODI Pharma AB as of 31/12/2020

Quarterly Report Q1 ODI Pharma AB as of 30/09/2020

Årsredovisning/Annual Report 2019/2020 [SWE]

Annual Report 2019/2020 ODI Pharma [ENG, unofficial translation]

Year-end Report Q4 ODI Pharma AB as of 30/06/2020

Quarterly Report Q3 ODI Pharma AB as of 31/03/2020

Half-year Report Q2 ODI Pharma AB as of 31/12/2019

Audit Report ODI Pharma AB as of 23/10/2019

Proforma Statement for the ODI Pharma Group as of 30/09/2019

ODI Pharma Schweiz AG

Financial Statements as of 30/06/2019

Financial Statements as of 30/09/2019

ODI Pharma Polska Sp. z o.o.

Financial Statements as of 31/12/2018

Financial Statements as of 30/09/2019

Articles and Memorandum of Association

ODI Pharma AB

Articles of Association

Memorandum of Association

Auditor

ODI Pharma AB

The Auditor of ODI Pharma AB is Öhrlings PricewaterhouseCoopers AB, Johan Engstam is elected auditor in charge.

Dates for release of financial information

ODI Pharma AB

July – September 2023 (Q1) 23rd of November 2023

Annual Report 2022/2023 23rd of November 2023

July - December 2023 (Q2) 22nd of February 2024

July 2023 - March 2024 (Q3) 30th of May 2024

July 2023 - June 2024 (Q4) 29th of August 2024